Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - Italy

NCT03003494 · clinicaltrials.gov ↗

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Spiolto® Respimat®

Sponsor

Boehringer Ingelheim